Literature DB >> 9494425

Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop.

B Wiedenmann1, R T Jensen, M Mignon, C I Modlin, B Skogseid, G Doherty, K Oberg.   

Abstract

In 1996 a consensus workshop on the preoperative diagnosis and surgical treatment of neuroendocrine tumor disease took place in Berlin. Although there was a consensus on the diagnosis and surgical treatment by world experts in neuroendocrine surgery in some areas, it became clear that certain management policies vary among centers. In large part, diverging policies reflect a lack of controlled studies. This paper summarizes the various opinions brought forward during this conference and emphasizes consensus approaches for the diagnosis and therapy of neuroendocrine neoplasms.

Entities:  

Mesh:

Year:  1998        PMID: 9494425     DOI: 10.1007/s002689900387

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.

Authors:  William C Chen; Richard R P Warner; Stephen C Ward; Noam Harpaz; Celia M Divino; Steven H Itzkowitz; Michelle K Kim
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Laparoscopic resection of a pancreatic polypeptidoma with a solitary liver metastasis.

Authors:  W-F Chan; C-Y Lo; C-M Lo; S-T Fan
Journal:  Surg Endosc       Date:  2004-03       Impact factor: 4.584

3.  Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas.

Authors:  Frederic Triponez; David Dosseh; Pierre Goudet; Patrick Cougard; Catherine Bauters; Arnaud Murat; Guillaume Cadiot; Patricia Niccoli-Sire; Jean-Alain Chayvialle; Alain Calender; Charles A G Proye
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 4.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

5.  Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE.

Authors:  Frederic Triponez; Pierre Goudet; David Dosseh; Patrick Cougard; Catherine Bauters; Arnaud Murat; Guillaume Cadiot; Patricia Niccoli-Sire; Alain Calender; Charles A G Proye
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 6.  The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines.

Authors:  Wouter T Zandee; Wouter W de Herder
Journal:  Neuroendocrinology       Date:  2018-01-10       Impact factor: 4.914

7.  The LARO-MEN1 study: a longitudinal clinical experience with octreotide Long-Acting Release in patients with Multiple Endocrine Neoplasia type 1 Syndrome.

Authors:  Federica Cioppi; Luisella Cianferotti; Laura Masi; Francesca Giusti; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

8.  Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?

Authors:  H Amthauer; J Ruf; M Böhmig; E Lopez-Hänninen; T Rohlfing; K-D Wernecke; U Plöckinger; M Gutberlet; A-J Lemke; T Steinmüller; B Wiedenmann; R Felix
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-03       Impact factor: 9.236

Review 9.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.

Authors:  David C Metz; Robert T Jensen
Journal:  Gastroenterology       Date:  2008-08-12       Impact factor: 22.682

10.  Thirty-Year Survival with an Untreated Malignant Duodenal Somatostatinoma.

Authors:  Jan Ulfberg; Tibor Tot; Erik Wilander
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.